Viewing Study NCT03636269

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2026-03-15 @ 8:36 AM
Study NCT ID: NCT03636269
Status: COMPLETED
Last Update Posted: 2022-04-26
First Post: 2018-08-03
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Sponsor: Cara Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Uremic Pruritus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hemodialysis View
None difelikefalin View
None CR845 View
None Pruritus View
None Chronic Itch View
None Itch View
None Itching View
None Uremic Pruritus View
None Dialysis View
None CKD View
None CKD-associated pruritus View
None CKD-aP View
None ESRD (end stage renal disease) View
None KALM View
None Chronic Kidney Disease View
None Kidney failure, chronic View
None Kidney dysfunction View
None Generalized pruritus View